Hadassah Medical Center

Futó vizsgálatok

• Még nem toboroz

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025).

  NCT07722611· 2/3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)

  NCT07743164· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)

  NCT07817875· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  NCT07623161· 3. fázis· Takeda· Forrás

• Toboroz

  Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

  NCT07804186· 3. fázis· IDEAYA Biosciences· Forrás

• Toboroz

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

  NCT07634471· 2/3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

  NCT07470879· 2. fázis· Pfizer· Forrás

• Toboroz

  A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

  NCT07483099· 2. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

  NCT07513376· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  NCT07483073· 2. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

  NCT07249905· 1/2. fázis· ModeX Therapeutics, An OPKO Health Company· Forrás

• Toboroz

  A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  NCT07392190· 3. fázis· Eli Lilly and Company· Forrás

• Fut, nem toboroz

  A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

  NCT07266441· 2. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

  NCT07222332· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  NCT07322003· 3. fázis· Prilenia· Forrás

• Még nem toboroz

  Metabolic Changes Associated With Weight Gain After Treatment of Achalasia

  NCT07334639· Assaf-Harofeh Medical Center· Forrás

• Toboroz

  A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

  NCT07222137· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  NCT07222566· 3. fázis· Pfizer· Forrás

• Toboroz

  A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

  NCT07063745· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  NCT07222800· 3. fázis· Pfizer· Forrás

• Toboroz

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  NCT07241390· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

  NCT07206225· 1. fázis· Pfizer· Forrás

• Toboroz

  Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

  NCT07223593· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Inactivated UPEC-FimON for Non Muscle Invasive Bladder Cancer After BCG or Intravesical Chemotherapy Failure

  NCT07881666· 1. fázis· Hopec Pharma· Forrás

• Toboroz

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  NCT06989437· 2/3. fázis· Pfizer· Forrás

• Toboroz

  Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  NCT07106762· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  NCT07144280· 3. fázis· Pfizer· Forrás

• Toboroz

  This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  NCT07028853· 3. fázis· Pfizer· Forrás

• Toboroz

  A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

  NCT06926868· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  NCT07115745· 1. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás

• Toboroz

  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  NCT06920004· 3. fázis· argenx· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

  NCT07062965· 3. fázis· Pfizer· Forrás

• Toboroz

  Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  NCT07064759· 3. fázis· 4D Molecular Therapeutics· Forrás

• Toboroz

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

  NCT07060807· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

  NCT06997497· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

  NCT07015983· 2. fázis· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Forrás

• Toboroz

  A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

  NCT06863272· 1/2. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· 3. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

  NCT06961006· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

  NCT06819891· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide

  NCT06497595· Sheba Medical Center· Forrás

• Toboroz

  A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

  NCT06499285· 3. fázis· Takeda· Forrás

• Fut, nem toboroz

  A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

  NCT06914895· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

  NCT06875310· 3. fázis· Mirati Therapeutics Inc.· Forrás

• Fut, nem toboroz

  Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)

  NCT06814145· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

  NCT06801834· 3. fázis· Gilead Sciences· Forrás

Showing 50 of 158.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák8 toboroz
• Crohn-betegség7 toboroz
• Mielóma multiplex6 toboroz
• Elhízás5 toboroz
• Follikuláris limfóma4 toboroz
• Prosztatarák4 toboroz
• 2-es típusú cukorbetegség3 toboroz
• Áttétes emlőrák3 toboroz
• Colitis ulcerosa3 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)3 toboroz
• Fej-nyaki daganatok3 toboroz
• Hólyagrák3 toboroz
• Vastagbélrák3 toboroz
• Akut limfoid leukémia (ALL)2 toboroz
• Akut mieloid leukémia (AML)2 toboroz
• Alzheimer-kór2 toboroz
• Epilepszia2 toboroz
• Gyermekkori daganatok2 toboroz
• Melanóma2 toboroz
• Mieloproliferatív neopláziák2 toboroz
• Myasthenia gravis2 toboroz
• Tripla negatív emlőrák2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• Amiloidózis1 toboroz
• Amiotrófiás laterálszklerózis (ALS)1 toboroz
• Aortic stenosis1 toboroz
• Bronchiectasis1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• Hasnyálmirigyrák1 toboroz
• Hipertrófiás kardiomiopátia1 toboroz
• Időskori makuladegeneráció1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
• Krónikus vesebetegség1 toboroz
• Lupus (SLE)1 toboroz
• Magas vérnyomás1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Neuroendokrin daganatok1 toboroz
• Peripheral artery disease1 toboroz
• Petefészekrák1 toboroz
• Rheumatoid arthritis1 toboroz
• Spinal cord injury1 toboroz
• Stroke (szélütés)1 toboroz
• Szarkóma1 toboroz
• Szisztémás szklerózis (szkleroderma)1 toboroz
• Szívelégtelenség1 toboroz
• Vesedaganat1 toboroz
• Zsírmáj (MASLD/MASH)1 toboroz

Lezárt vizsgálatok

• Lezárult

  GV101 in Healthy Obese Participants

  NCT06979505· 2. fázis· Graviton Bioscience Corporation· Forrás

• Lezárult

  Whey Protein Milk-Derived Exosomes

  NCT06755021· Exosomm Ltd.· Forrás

• Lezárult

  Validate: Trustworthy AI to Improve Acute Stroke Outcomes

  NCT05622539· Hospital Universitari Vall d'Hebron Research Institute· Forrás

• Toboroz

  A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

  NCT06285318· Janssen-Cilag Ltd.· Forrás

• Lezárult

  Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)

  NCT06045507· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

  NCT05952856· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH)

  NCT05952869· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

  NCT05483907· 2. fázis· Bridge Biotherapeutics, Inc.· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Study of Vedolizumab in Adults With Crohn's Disease (CD)

  NCT05192863· Takeda· Forrás

• Leállították

  A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

  NCT05592275· 2. fázis· Eli Lilly and Company· Forrás

• Lezárult

  A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05595642· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

  NCT05514548· 2. fázis· Inversago Pharma Inc.· Forrás

• Lezárult

  Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

  NCT05525520· 2. fázis· Escient Pharmaceuticals, Inc· Forrás

• Lezárult

  A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

  NCT04919512· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

  NCT05238675· 2. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

  NCT05219617· 3. fázis· SK Life Science, Inc.· Forrás

• Lezárult

  Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC

  NCT05059327· 2. fázis· Noema Pharma AG· Forrás

• Lezárult

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

  NCT05186818· 3. fázis· Cytokinetics· Forrás

• Toboroz

  A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

  NCT05139017· 2/3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study to Evaluate Zilovertamab Vedotin (MK-2140) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-004)

  NCT05144841· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  NCT04892173· 3. fázis· Johnson & Johnson Enterprise Innovation Inc.· Forrás

• Lezárult

  Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis

  NCT05199337· 1/2. fázis· K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.· Forrás

• Leállították

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· 3. fázis· InDex Pharmaceuticals· Forrás

• Lezárult

  Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)

  NCT05008224· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002)

  NCT05038800· 1. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

  NCT04847557· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· 3. fázis· Apellis Pharmaceuticals, Inc.· Forrás

• Lezárult

  A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

  NCT04657224· 1. fázis· Janssen Research & Development, LLC· Forrás

• Leállították

  A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement

  NCT04543188· 1. fázis· Pfizer· Forrás

• Leállították

  Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion

  NCT04529954· 1/2. fázis· Cerebral Therapeutics LLC· Forrás

• Lezárult

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM

  NCT04471844· NovoCure Ltd.· Forrás

• Lezárult

  Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

  NCT04671433· 3. fázis· MeiraGTx Ocular UK Ltd· Forrás

• Lezárult

  A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

  NCT04540796· 1. fázis· Janssen Research & Development, LLC· Forrás

• Leállították

  Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization

  NCT04153175· 2. fázis· Cerebral Therapeutics LLC· Forrás

• Lezárult

  A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

  NCT04255433· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

  NCT04166773· 2. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula

  NCT04075825· 3. fázis· Takeda· Forrás

• Lezárult

  A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

  NCT03899259· 3. fázis· Eli Lilly and Company· Forrás

• Lezárult

  Rostock International Parkinson's Disease Study (ROPAD)

  NCT03866603· CENTOGENE GmbH Rostock· Forrás

• Lezárult

  Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

  NCT03778931· 3. fázis· Stemline Therapeutics, Inc.· Forrás

• Lezárult

  A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

  NCT03900598· 1. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

  NCT03790332· 1/2. fázis· Pharmacyclics LLC.· Forrás

• Lezárult

  CERENOVUS Neurothrombectomy Devices Registry

  NCT03685578· Cerenovus, Part of DePuy Synthes Products, Inc.· Forrás

• Lezárult

  A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

  NCT03573310· 1. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])

  NCT03517449· 3. fázis· Eisai Inc.· Forrás

• Lezárult

  Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

  NCT03377491· 3. fázis· NovoCure Ltd.· Forrás

• Lezárult

  A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens

  NCT03412565· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]

  NCT03555422· 3. fázis· Karyopharm Therapeutics Inc· Forrás

Showing 50 of 61.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Cisztás fibrózis20 munka · 0 vizsgálat
• Időskori makuladegeneráció12 munka · 5 vizsgálat
• Arthritis psoriatica12 munka · 0 vizsgálat
• Neuroendokrin daganatok11 munka · 1 vizsgálat
• Cytomegalovirus infection9 munka · 0 vizsgálat
• Retinitis pigmentosa4 munka · 3 vizsgálat